Tuesday - June 02, 2026

Category Archives: Science

Systemic Lupus Erythematosus Clinical Trial Pipeline Shows Potential with Active Contributions from 120+ Key Companies | DelveInsight

DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insights 2026” report provides comprehensive insights about 120+ companies and 140+ pipeline drugs in Systemic Lupus Erythematosus pipeline landscape. It covers the Systemic Lupus Erythematosus pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Presbyopia Clinical Trial Pipeline Gains Momentum: 6+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Presbyopia Pipeline Insight 2026” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in the Presbyopia pipeline landscape. It covers the Presbyopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Presbyopia pipeline … Continue reading →

Angelman Syndrome Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Angelman Syndrome Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Angelman Syndrome pipeline landscape. It covers the Angelman Syndrome Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Phenylketonuria (PKU) Market is Expected to Witness Significant Growth by 2036 Owing to Emerging Gene-Based and Metabolic Therapies | DelveInsight

The market dynamics for Phenylketonuria (PKU) are witnessing substantial growth driven by increasing neonatal screening programs, growing awareness regarding inherited metabolic disorders, advancements in genetic diagnostics, and the development of novel therapies aimed at improving long-term phenylalanine control. Additionally, the … Continue reading →

Schizophrenia Market is Expected to Expand Significantly by 2036 Owing to Rising Disease Burden and Launch of Novel Antipsychotic Therapies | DelveInsight

The Schizophrenia market is witnessing growth due to the rising prevalence of schizophrenia, increasing mental health awareness, advancements in psychiatric research, and the adoption of long-acting injectable therapies. Moreover, emerging therapies such as olanzapine LAI (TEV-’749), ulotaront (SEP-363856), brilaroxazine (RP-5063), … Continue reading →

Acute Liver Failure Market is Anticipated to Grow by 2036 Owing to Rising Incidence of Drug-Induced Liver Injury and Emerging Regenerative Therapies | DelveInsight

The market dynamics for Acute Liver Failure (ALF) are witnessing steady growth driven by the rising incidence of drug-induced liver injury, increasing acetaminophen toxicity cases, growing burden of viral hepatitis-associated liver failure, and advancements in supportive critical care management. Additionally, … Continue reading →

Cernum Biosciences Review: “No Clumping, Perfect Vacuum, High Purity”

Verified customer review highlighting product quality, vacuum integrity, purity standards, fast delivery, and professional service from Cernum Biosciences. Cernum Biosciences review from a verified buyer highlights product quality, fast delivery, and professional customer service. Cernum Biosciences review feedback continues to … Continue reading →

K-38 Consulting Releases Biotech CFO Services Case Study, Demonstrating How Strategic Financial Leadership Supports Innovation, Cash Flow Stability, and Scalable Growth

Raleigh, NC – May 28th, 2026 – K-38 Consulting, a leading outsourced CFO and financial advisory firm, announces the release of its latest biotech CFO services case study, highlighting how biotechnology companies can strengthen financial operations, improve capital efficiency, and support … Continue reading →

AI Earned Mostly B’s and C’s in a 2021 College Study. Five Years Later, A Grades Are Up 13 Percentage Points in AI-Exposed Courses.

We graded AI on college papers in 2021. In 2026, A’s are up where they matter most. Before ChatGPT existed, professors blind-graded GPT-3 alongside undergraduate writers. New research analyzing more than 500,000 student-course enrollments suggests A grades are now rising … Continue reading →